DRMAW Dermata Therapeutics, Inc. Warrant
$0.00▼ -50.00%
Unknown
Other
Volume 146.1K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.00 - 0.00
% vs 50 MA
-95.77%
% vs 200 MA
–%
RSI-14
29.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$2.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.01M
COGS
–
Operating Exp
$3.01M
Operating Income
-$3.01M
EBIT
-$3.01M
Pretax Income
-$2.97M
Net Income
-$2.97M
Price & Volume History
Loading chart…
Recent News
WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338
PR Newswire · Sep 11, 2026 6:00 PM
Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338
ACCESS Newswire · Sep 11, 2026 5:22 PM
Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories
GlobeNewswire · Aug 31, 2026 9:05 AM
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
ACCESS Newswire · Aug 25, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DRMAW's money flow as a full page
Social Sentiment
No Reddit posts found for DRMAW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.